Chem. J. Chinese Universities ›› 2018, Vol. 39 ›› Issue (10): 2350.doi: 10.7503/cjcu20180124

• Polymer Chemistry • Previous Articles    

β-Cyclodextrin Based Star-like Polymer for Loading Chlorambucil

CHEN Tao*(), HUANG Chan   

  1. Shanghai Key Laboratory of Advanced Polymeric Materials, School of Materials Science and Engineering,East China University of Science and Technology, Shanghai 200237, China
  • Received:2018-02-09 Online:2018-09-29 Published:2018-09-29
  • Contact: CHEN Tao E-mail:tchen@ecust.edu.cn
  • Supported by:
    † Supported by the National Key Research and Development Program of China(Nos. 2017YFB0309301, 2017YFB0309302) and the Natural Science Foundation of Shanghai, China(No. 17ZR1407200).

Abstract:

Star-like polymer with β-cyclodextrin core(β-CD) and poly(N,N-dimethylaminoethyl methacrylate) arms(PDMAEMA), β-CD-PDMAEMA, was synthesized by atom transfer radical polymerization using brominated β-CD as initiator. The structure of the polymer was determined by Fourier transform infrared spectrophotometer(FTIR) and 1H nuclear magnetie resonance(NMR). The polymer was used to load hydrophobic anticancer drug chlorambucil(CLB) in both ethanol and water. The loading efficiency of CLB and in vitro release performance and mechanism at 37 ℃ in buffer solutions with various pH values were investigated by UV absorption spectroscopy. The results show that, compared to that in ethanol, the hydrophobic internal cavity of β-CD in the core of the star-like polymer includes more CLB in water, which leads to higher drug loading ratio, shorter and less burst release. The release of CLB from the star-like polymer follows the diffusion mechanism. The release rate and cumulative release amount of CLB are affected by the protonation degree of PDMAEMA arms, which results to pH responsive release behavior. The acidic condition is beneficial to more efficient and sustained release of CLB.

Key words: Poly(N, N-dimethylaminoethyl methacrylate), β-Cyclodextrin;, Chlorambucil, Host-guest interaction

CLC Number: 

TrendMD: